Glanbia PLC
F:GL9
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
G
|
Glanbia PLC
F:GL9
|
IE |
|
C
|
Citius Oncology Inc
NASDAQ:CTOR
|
US |
|
Frontier Developments PLC
LSE:FDEV
|
UK |
|
T
|
Toray Industries Inc
OTC:TRYIY
|
JP |
|
M
|
Mogo Inc
F:SGCC
|
CA |
|
W
|
Wartsila Oyj Abp
DUS:MTA
|
FI |
|
Metrospaces Inc
OTC:MSPC
|
US |
|
E
|
E Pairis SA
ATHEX:PAIR
|
GR |
|
C
|
CareCloud Inc
NASDAQ:CCLD
|
US |
|
I
|
Isu Petasys Co Ltd
KRX:007660
|
KR |
|
D
|
Daol Investment Co Ltd
KOSDAQ:298870
|
KR |
|
T
|
Tharisa PLC
JSE:THA
|
CY |
Wall Street
Price Targets
GL9 Price Targets Summary
Glanbia PLC
According to Wall Street analysts, the average 1-year price target for
GL9
is 17.55 EUR
with a low forecast of 13.99 EUR and a high forecast of 20.96 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is GL9's stock price target?
Price Target
17.55
EUR
According to Wall Street analysts, the average 1-year price target for
GL9
is 17.55 EUR
with a low forecast of 13.99 EUR and a high forecast of 20.96 EUR.
What is Glanbia PLC's Revenue forecast?
Projected CAGR
4%
For the last 14 years the
compound annual growth rate for
Glanbia PLC's revenue is
3%.
The projected
CAGR
for the next 3 years is
4%.
What is Glanbia PLC's Operating Income forecast?
Projected CAGR
9%
For the last 14 years the
compound annual growth rate for
Glanbia PLC's operating income is
6%.
The projected
CAGR
for the next 3 years is
9%.
What is Glanbia PLC's Net Income forecast?
Projected CAGR
32%
For the last 14 years the
compound annual growth rate for
Glanbia PLC's net income is
4%.
The projected
CAGR
for the next 3 years is
32%.
